MICROPORT CARDIO.MEDTECH. (72X) — Net Asset Quality Index
MICROPORT CARDIO.MEDTECH. (72X) has a Net Asset Quality Index of 83.1% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.67 Billion minus total liabilities of €450.55 Million yields net assets of €2.22 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check MICROPORT CARDIO.MEDTECH. asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
MICROPORT CARDIO.MEDTECH. Net Asset Quality Index Over Time (2021–2024)
This chart shows how MICROPORT CARDIO.MEDTECH.'s Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the index stands at 83.1%, representing net assets of €2.22 Billion against total assets of €2.67 Billion EUR. See working capital to net assets of MICROPORT CARDIO.MEDTECH. to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for MICROPORT CARDIO.MEDTECH. (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for MICROPORT CARDIO.MEDTECH. from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see MICROPORT CARDIO.MEDTECH. market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 83.0% | €2.22 Billion | €2.68 Billion | €454.07 Million | ▼ -7.6 pp |
| 2023 | 90.6% | €2.33 Billion | €2.58 Billion | €242.25 Million | ▼ -1.2 pp |
| 2022 | 91.8% | €2.75 Billion | €3.00 Billion | €247.55 Million | ▼ -0.4 pp |
| 2021 | 92.1% | €3.10 Billion | €3.36 Billion | €265.52 Million | — |